| Literature DB >> 28861206 |
Seung Yong Lee1, Dae-Geun Jeon1, Wan Hyeong Cho1, Won Seok Song1, Chang-Bae Kong1.
Abstract
BACKGROUND: Because of the high complication rate of anatomical reconstruction after periacetabular resection, the strategy of resection alone has been revisited. However, in terms of complications and functional outcome, whether resection hip arthroplasty (RHA) shows a superior result to that of pelvic ring reconstruction remains controversial.Entities:
Keywords: Acetabulum; Reconstructive surgery; Treatment outcome
Mesh:
Year: 2017 PMID: 28861206 PMCID: PMC5567034 DOI: 10.4055/cios.2017.9.3.374
Source DB: PubMed Journal: Clin Orthop Surg ISSN: 2005-291X
Demographic Data of 24 Patients with Resection Hip Arthroplasty
| Case | Age (yr)/sex | Diagnosis | Tumor stage | TV (cc) | Extent of iliac lesion (cm) | Resection type | Surgical margin | Surgical time (hr) | RBC transfusion (pint)* | LR | Meta. | Final status | F/U (mo) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 21/F | GCT | Benign | 115 | 2.3 | II | m | 2.2 | 7 | + | - | NED | 54 |
| 2 | 17/F | OS | IIB | 145 | 1.2 | II + III | w | 4.8 | 1 | - | - | CDF | 70 |
| 3 | 17/F | CS | IIB | 648 | 1 | II + III | w | 4.8 | 10 | - | - | CDF | 182 |
| 4 | 32/M | GCT | Benign | 66 | 0 | II + III† | m | 2.7 | 2 | + | - | NED | 118 |
| 5 | 43/F | FS | IIB | 111 | 1.7 | II + III | w | 3.9 | 4 | - | + | DOD | 41 |
| 6 | 47/F | CS | IIB | 172 | 0 | II + III | w | 5.1 | 2 | - | - | CDF | 61 |
| 7 | 68/M | CS | IIB | 103 | 2.5 | II + III | m | 4.8 | 11 | + | - | AWD | 66 |
| 8 | 34/M | CS | IIB | 66 | 4.5 | I† + II | w | 1.8 | 2 | - | - | CDF | 37 |
| 9 | 43/M | CS | IIB | 165 | 4.9 | I† + II | w | 1.7 | 0 | - | - | CDF | 35 |
| 10 | 46/M | CS | IIA | 87 | 3.7 | I† + II | w | 2.0 | 0 | - | - | CDF | 32 |
| 11 | 47/M | CS | IIA | 67 | 3.4 | I† + II | w | 1.7 | 3 | - | - | CDF | 29 |
| 12 | 15/M | SS | III | 165 | 1.7 | I† + II + III | m | 2.7 | 4 | - | - | CDF | 37 |
| 13 | 21/M | SS | III | 147 | 2.5 | I† + II + III | m | 4.7 | 9 | - | - | CDF | 280 |
| 14 | 22/M | OS | IIB | 330 | 0.9 | I† + II + III | w | 8.8 | 12 | - | - | CDF | 69 |
| 15 | 27/M | OS | IIB | 125 | 3.3 | I† + II + III | m | 5.4 | 7 | - | - | CDF | 43 |
| 16 | 30/M | GCT | Benign | 144 | 5 | I† + II + III† | w | 5.5 | 10 | - | - | CDF | 132 |
| 17 | 32/M | OS | IIB | 204 | 2.2 | I† + II + III | w | 5.0 | 11 | - | - | CDF | 26 |
| 18 | 34/F | CS | IIB | 414 | 2 | I† + II + III | w | 5.8 | 8 | - | - | CDF | 301 |
| 19 | 36/F | OS | IIB | 383 | 4.4 | I† + II + III | m | 5.2 | 20 | + | + | DOD | 36 |
| 20 | 39/M | CS | IIB | 116 | 0 | I† + II + III | w | 5.1 | 4 | - | - | CDF | 56 |
| 21 | 41/M | CS | IIB | 212 | 3.4 | I† + II + III | m | 2.9 | 6 | + | + | NED | 26 |
| 22 | 46/M | CS | IIB | 725 | 8 | I† + II + III | i | 3.5 | 12 | + | - | NED | 42 |
| 23 | 61/M | CS | IIB | 565 | 1.6 | I† + II + III | m | 5.9 | 15 | - | - | CDF | 35 |
| 24 | 65/M | CS | IIB | 162 | 3.4 | I† + II + III | w | 5.5 | 5 | - | - | CDF | 69 |
TV: tumor volume, iliac lesion: measured from the top of the femoral head, RBC: red blood cell, LR: local recurrence, Meta.: metastasis, GCT: giant cell tumor, m: marginal, +: local recurrence confirmed, NED: no evidence of disease, OS: osteosarcoma, w: wide, CDF: continuous disease-free, CS: chondrosarcoma, FS: fibrosarcoma, DOD: died of disease, AWD: alive with disease, SS: synovial sarcoma, i: intralesional.
*RBC 1 pint: 400 cc. †Partial resection of involved bone.
Demographic Data of 16 Patients with Pasteurized Autograft-Prosthesis Composite Reconstruction
| Case | Age (yr)/sex | Diagnosis | Tumor stage | TV (cc) | Resection type | Surgical margin | Surgical time (hr) | RBC transfusion (pint)* | LR | Meta. | Final status | F/U (mo) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 35/M | OS | IIB | 52 | II | w | 7 | 6 | - | + | DOD | 24 |
| 2 | 19/F | GCT | Benign | 0188 | II + III | w | 5.8 | 8 | - | - | CDF | 271 |
| 3 | 20/F | OS | IB | 63 | II + III | m | 7 | 7 | - | - | CDF | 246 |
| 4 | 49/F | HES | IB | 187 | II + III† | w | 6.4 | 6 | - | - | CDF | 243 |
| 5 | 52/M | CS | IIB | 251 | II + III | w | 8 | 9 | - | - | CDF | 125 |
| 6 | 54/F | CS | IIB | 110 | II + III | w | 6.3 | 9 | - | - | CDF | 108 |
| 7 | 18/F | ES | IIB | 201 | I† + II | m | 7.3 | 7 | + | + | DOD | 13 |
| 8 | 20/F | OS | IIB | 377 | I† + II | m | 7.6 | 16 | - | - | CDF | 150 |
| 9 | 21/M | MFH | IIB | 31 | I† + II | w | 7.3 | 5 | - | - | CDF | 254 |
| 10 | 24/F | DF | Benign | 82 | I† + II | m | 6.8 | 9 | - | - | CDF | 120 |
| 11 | 34/F | MC | III | 79 | I† + II | w | 7.9 | 13 | + | - | NED | 224 |
| 12 | 54/F | MC | III | 26 | I† + II | w | 6.6 | 7 | - | - | CDF | 161 |
| 13 | 25/M | CS | IIB | 653 | I† + II + III† | m | 9.3 | 15 | - | - | CDF | 141 |
| 14 | 30/M | OS | IIB | 226 | I† + II + III | w | 7.3 | 4 | + | + | DOD | 69 |
| 15 | 31/F | CS | IIB | 63 | I† + II + III† | w | 6.8 | 8 | - | - | CDF | 63 |
| 16 | 45/M | CS | IIB | 141 | I† + II + III | w | 7.3 | 10 | + | + | DOD | 21 |
TV: tumor volume, RBC: red blood cell, LR: local recurrence, Meta.: metastasis, OS: osteosarcoma, w: wide, +: local recurrence confirmed, DOD: died of disease, GCT: giant cell tumor, CDF: continuous disease-free, m: marginal, HES: hemangioendothelioma, CS: chondrosarcoma, ES: Ewing sarcoma, MFH: malignant fibrous histiocytoma, DF: desmoplastic fibrosarcoma, MC: metastatic carcinoma, NED: no evidence of disease.
*RBC 1 pint: 400 cc. †Partial resection of involved bone.
Fig. 1(A) The axial pelvic computed tomography (CT) shows complete bony neo-acetabulum formation 9 months postoperatively. (B) The axial CT shows partial bony neo-acetabulum formation (less than 1/2 of the femoral head circumference).
Comparison of Tumor Characteristics and Surgical Outcome between Resection Hip Arthroplasty (n = 24) and Pasteurized Autograft-Prosthesis Composite Reconstruction (n = 16)
| Variable | Resection hip arthroplasty (%) | Pasteurized autograft-prosthesis composite reconstruction (%) | |
|---|---|---|---|
| Age (yr) | 0.505 | ||
| ≤ 40 | 14 (58.3) | 11 (68.8) | |
| > 40 | 10 (41.7) | 5 (31.2) | |
| Sex | 0.037 | ||
| Male | 17 (70.8) | 6 (37.5) | |
| Female | 7 (29.2) | 10 (62.5) | |
| Initial tumor volume (cc) | |||
| Mean (range) | 226.5 (66–725) | 170.6 (26–653) | 0.334 |
| ≤ 150 | 12 (50.0) | 9 (56.3) | 0.698 |
| > 150 | 12 (50.0) | 7 (43.7) | |
| Resection type | 0.581 | ||
| I + II + III | 17 (70.8) | 10 (62.5) | |
| II + III | 7 (29.2) | 6 (37.5) | |
| Surgical time (hr) | |||
| Mean (range) | 4.2 (1.7–8.8) | 7.2 (5.8–9.3) | < 0.001 |
| ≤ 6 | 23 (95.8) | 1 (6.3) | < 0.001 |
| > 6 | 1 (4.2) | 15 (93.8) | |
| Transfusion (pint) | |||
| Mean (range) | 6.9 (0–20) | 8.7 (4–16) | 0.219 |
| ≤ 6 | 12 (50.0) | 4 (25.0) | 0.114 |
| > 6 | 12 (50.0) | 12 (75.0) | |
| Surgical margin | 0.505 | ||
| Wide | 14 (58.3) | 11 (68.8) | |
| Marginal, intralesional | 10 (41.7) | 5 (31.2) | |
| Major complication | < 0.001 | ||
| Present | 0 | 12 (75.0) | |
| Absent | 24 (100) | 4 (25.0) | |
| Minor complication | < 0.001 | ||
| Present | 2 (8.3) | 15 (6.3) | |
| Absent | 22 (91.7) | 1 (93.7) | |
| Final leg length discrepancy (cm) | |||
| Mean (range) | 3.7 (1.3–6.4) | 3.7 (0–7) | 0.943 |
| ≤ 3.0 | 10 (41.7) | 6 (37.5) | 0.792 |
| > 3.0 | 14 (58.3) | 10 (62.5) | |
| MSTS score | |||
| Mean (range) | 23.5 (15–28) | 14.8 (8–26) | < 0.001 |
| ≤ 20 | 6 (25.0) | 13 (81.3) | 0.001 |
| > 20 | 18 (75.0) | 3 (18.8) | |
| Local recurrence | 1.000 | ||
| Recurred | 6 (25.0) | 4 (25.0) | |
| Not recurred | 18 (75.0) | 12 (75.0) | |
| Distant metastasis | 0.407 | ||
| Occurred | 3 (12.5) | 4 (25.0) | |
| Not occurred | 21 (87.5) | 12 (75.0) | |
| Final outcome | 0.138 | ||
| Alive | 23 (95.8) | 12 (75.0) | |
| Dead | 1 (4.2) | 4 (25.0) | |
| Total | 24 (100) | 16 (100) |
MSTS: Musculoskeletal Tumor Society.
Postoperative Course and Functional Outcome of 16 Patients with Pasteurized Autograft-Prosthesis Composite Reconstruction
| Case | Major complication | Management of major complication (no. of operations) | Minor complication | Management of minor complication (no. of operations) | Final status (months from index operation to prosthesis removal) | Final LLD (cm) | MSTS score before prosthesis removal | Final MSTS score |
|---|---|---|---|---|---|---|---|---|
| 1 | Graft fracture | Prosthesis removal (1) | Infection | Debridement (1) | Pseudoarthrosis (12) | 4 | 22 | 12 |
| 2 | Acetabular cup loosening, graft fracture | Cup revision (1), saddle prosthesis (1) | Infection, proximal migration of saddle prosthesis | Incision and drainage (4) | Saddle prosthesis (125) | 6 | 28 | 11 |
| 3 | Graft fracture | Saddle prosthesis (1) | Plate pull out | Plate removal (1) | Saddle prosthesis (89) | 5 | 24 | 9 |
| 4 | Graft fracture, dislocation | Cup revision (1), saddle prosthesis (1) | Saddle mechanism failure | Revision (3) | Saddle prosthesis (98) | 7 | 27 | 8 |
| 5 | Infection | Prosthesis removal (1) | Dislocation | Closed reduction (1) | Pseudoarthrosis (12) | 5 | 19 | 15 |
| 6 | Graft fracture | Prosthesis removal (1) | Plate fracture, pin protrusion | Foreign body removal (2) | Pseudoarthrosis (62) | 3 | 21 | 14 |
| 7 | - | - | Autograft infection | Debridement (1) | Intact | 0 | - | 15 |
| 8 | Graft fracture | Prosthesis removal (1) | - | - | Pseudoarthrosis (4) | 5 | 18 | 18 |
| 9 | Graft resorption, cup loosening | Cup revision (2), bone graft (1), prosthesis removal (1) | Dislocation, infection | Open reduction (2), debridement (2) | Pseudoarthrosis (218) | 6 | 28 | 12 |
| 10 | Dislocation | Cup revision (1) | Dislocation | Open reduction (3) | Intact | 0 | - | 26 |
| 11 | Graft fracture | Prosthesis removal (1) | Dislocation | Open reduction (1) | Pseudoarthrosis (95) | 7 | 26 | 14 |
| 12 | - | - | Dislocation | Open reduction (1) | Intact | 0 | - | 22 |
| 13 | Infection | Prosthesis removal (1) | - | - | Pseudoarthrosis (1) | 6 | 15 | 14 |
| 14 | Nonunion | Prosthesis removal (1) | Wound infection | Debridement (1) | Pseudoarthrosis (11) | 5 | 19 | 9 |
| 15 | - | - | Dislocation | Open reduction (1) | Intact | 0 | - | 24 |
| 16 | - | - | - | - | Intact | 0 | - | 14 |
LLD: limb length diascrepancy, MSTS: Musculoskeletal Tumor Society.
Postoperative Course and Functional Outcome of 24 Patients with Resection Hip Arthroplasty
| Case | Osteotomy level from iliac crest (cm) | Fixation (femoral head to ilium) | Postoperative immobilization | Bony neo-acetabulum/time to neo-acetabulum formation (mo) | Complication | Limb length discrepancy (cm) | Shoe heel height (cm) | Walking aid | MSTS score |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 10.5 | None* | None | Complete/9 | - | 2.6 | None | None | 28 |
| 2 | 9 | None | None | Complete/13 | - | 3 | 1 | None | 25 |
| 3 | 11 | Wire | Hip spica cast | None/NA | - | 3 | 1.5 | None | 24 |
| 4 | 14.5 | None | None | Partial/8 | - | 1.3 | None | None | 28 |
| 5 | 10.7 | Wire | None | Partial/6 | - | 3 | 1.5 | None | 25 |
| 6 | 10.7 | None | None | Partial/7 | Re-exploration | 3.3 | 2 | None | 25 |
| 7 | 8.2 | None | None | Partial/6 | - | 2.4 | None | None | 24 |
| 8 | 9.2 | None* | None | Complete/6 | - | 3.1 | 2 | None | 26 |
| 9 | 9.3 | Wire* | None | Partial/7 | - | 4.3 | 3 | 1 Cane | 19 |
| 10 | 10 | None* | None | Partial/6 | - | 3.5 | 2 | None | 25 |
| 11 | 10 | None* | None | Partial/5 | Flap necrosis | 2.4 | None | None | 27 |
| 12 | 9.3 | Wire* | None | Complete/4 | - | 2 | None | None | 28 |
| 13 | 10.5 | Wire | Hip spica cast | None/NA | - | 4.7 | 3 | 1 Cane | 19 |
| 14 | 11.2 | Wire | None | Complete/7 | - | 4.7 | 3 | None | 25 |
| 15 | 9 | Wire* | None | Complete/6 | - | 4.5 | 3 | None | 26 |
| 16 | 9 | None | None | None/NA | - | 5.8 | 3 | 1 Cane | 19 |
| 17 | 9.4 | Wire* | None | Complete/6 | - | 2.5 | None | None | 27 |
| 18 | 9.6 | Wire | Hip spica cast | Partial/13 | - | 5.2 | 3 | None | 22 |
| 19 | 6.6 | Wire* | None | None/NA | Chronic pain | 6.4 | 3 | 1 Crutch | 17 |
| 20 | 9 | None | None | None/NA | - | 6 | 4 | 1 Crutch | 25 |
| 21 | 8.8 | Wire* | None | None/NA | - | 4.5 | 3 | 1 Cane | 18 |
| 22 | 4 | None* | None | None/NA | - | 5.5 | 3 | 1 Crutch | 15 |
| 23 | 10 | Wire* | None | Partial/5 | Re-exploration | 2.4 | None | None | 24 |
| 24 | 8.8 | None | None | None/NA | - | 3.7 | 2 | None | 23 |
MSTS: Musculoskeletal Tumor Society, NA: not assessed, Re-exploration: during follow-up, exploration of a lesion suspicious of local recurrence on magnetic resonance imaging turned out to be a new bone in neo-acetabulum formation.
*During surgery, 2 or 3 iliac wing osteotomies were carried out to preserve the iliac crest-hip flexor or abductor muscle continuity.
Fig. 2(A) The preoperative plain radiograph shows a mixed osteolytic and sclerotic lesion in the right ilium and acetabulum in a 34-year-old male patient with chondrosarcoma (case 8). (B) The postoperative plain radiograph shows Enneking type II + I (partial) resection and repositioning of the previously detached iliac bone block-muscle complex with wire. (C) The follow-up plain radiograph shows complete neo-hip joint formation; the patient is fully active with shortening by 3 cm.
Fig. 3(A) The plain radiograph shows an osteolytic lesion in the right acetabulum in a 41-year-old patient with chondrosarcoma (case 21). (B) The postoperative radiograph demonstrates Enneking type I (partial) + II + III (partial) resection and the femoral head fixed to the remaining iliac wing with a single wire. (C) At 6 months postoperatively, because of the high iliac osteotomy level, only partial bony neo-acetabulum had formed. The patient had no pain and could walk with one cane.
Comparison with Previous Studies
| Study | No. of patients | Type of pelvic reconstruction (n) | Deep infection (%) | Amputation due to infection (%) | Reconstruction failure (%) | Local recurrence (%) | Mean MSTS score/LLD (cm) |
|---|---|---|---|---|---|---|---|
| Current series | 40 | PPC (16) | 2/16 (12) | 0 | 11/16 (69) | 3/16 (18) | 14.8/3.7 |
| Hu et al. (2012) | 27 | RHA | 0 | 0 | 0 | 0 | 22.6/5 |
| Angelini et al. (2014) | 270 | No reconstruction (133) | 20/133 (15) | 5/55 (9) | 16/137 (11) Reconstruction removed for infection | NA | NA |
| Gebert et al. (2011) | 62 | Hip transposition | 20/62 (32) | 1/62 (1) | 25/62 (40) Had revision | 6/62 (9.6) | 18.6/5 |
| Donati et al. (2011) | 35 | APC | 8/35 (22) | 0 | 15/35 (42) | 3/35 (8.5) | 21.6/NA |
| Jaiswal et al. (2008) | 98 | Pelvic prosthesis | 17/98 (18) | 1/98 (1) | 22/98 (23.7) | 29/98 (31) | 59.4% (TESS) |
MSTS: Musculoskeletal Tumor Society, LLD: leg length discrepancy, PPC: pasteurized autograft-prosthesis composite, RHA: resection hip arthroplasty, APC: allograft prosthesis composite, NA: not assessed, TESS: Toronto Extremity Salvage Score.